K. Miyoshi

Down-Regulation: Another Possible Advantage of 2 Agonists in Asthmatic Therapy

S. Horio, H. Fukui, N. Kawakami, 2004 .

Down‐regulation of histamine H1 receptors by β2‐adrenoceptor‐mediated inhibition of H1 receptor gene transcription

K. Fujimoto, S. Horio, H. Fukui, 2008, The Journal of pharmacy and pharmacology.

Heterologous up‐regulation of the histamine H1 receptor by M3 muscarinic receptor‐mediated activation of H1‐receptor gene transcription

A. Das, K. Fujimoto, S. Horio, 2007, The Journal of pharmacy and pharmacology.

Histamine H1 receptor down-regulation mediated by M3 muscarinic acetylcholine receptor subtype.

Yousuke Wakayama, S. Horio, H. Fukui, 2004, Journal of pharmacological sciences.

Beta(2)-adrenergic receptor-mediated histamine H(1) receptor down-regulation: another possible advantage of beta(2) agonists in asthmatic therapy.

S. Horio, H. Fukui, N. Kawakami, 2004, Journal of pharmacological sciences.

Homologous and heterologous phosphorylations of human histamine H1 receptor in intact cells.

S. Horio, H. Fukui, N. Kawakami, 2004, Journal of pharmacological sciences.

Direct phosphorylation of histamine H1 receptor by various protein kinases in vitro.

S. Horio, H. Fukui, T. Yamauchi, 2003, Methods and Findings in Experimental and Clinical Pharmacology.

Recent advances in molecular pharmacology of the histamine systems: regulation of histamine H1 receptor signaling by changing its expression level.

A. Das, K. Fujimoto, S. Horio, 2006, Journal of pharmacological sciences.

Inhibition of histamine H1 receptor downregulation by KT5823, a protein kinase G inhibitor.

S. Horio, H. Fukui, N. Kawakami, 2003, Methods and findings in experimental and clinical pharmacology.